Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $755.50
Hundreds of people in the UK with a rare and incurable type of blood cancer are set to benefit from a new drug that h ...
Pfizer Inc on Tuesday raised its annual guidance, as it reported strong growth in quarterly sales. The New York City ...
ridge, Surrey-based consumer healthcare firm spun-out of GSK PLC in 2022 - Announces it has completed an off-market pu ...
Pfizer Inc sold a 7.6% stake in consumer health products firm Haleon PLC for GBP2.7 billion, the investment banks run ...
Pfizer Inc on Monday said it plans to sell a 5.9% stake in consumer products firm, Haleon PLC, in a deal that could r ...
A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to ...
Pfizer Inc on Monday reported positive results from patients involved in phase 2 studies of ponsegromab and Braftovi ...
Pfizer Inc upped its yearly outlook on the back of a "strong" second-quarter, and the pharmaceutical firm added that ...
Pfizer Inc reported a drop in profit on lower sales of Covid-19 related profit Wednesday as it steers investments to ...
A row between pharmaceutical firms Moderna Inc and Pfizer Inc/BioNTech comes to court in London on Tuesday over paten ...
Pfizer Inc on Tuesday announced positive top-line results from a Phase 3 study of Abrysvo in adults aged 18 to 59 at ...
Haleon PLC on Thursday said it bought back around GBP315 million in shares from Pfizer Inc. Haleon, a Weybridge, Sur ...
Haleon PLC on Tuesday said it has agreed to repurchase 102.3 million shares off-market from Pfizer Inc, as part of th ...
Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought ...
York-based pharmaceuticals manufacturer - Says European Commission approves Pfizer’s Prevenar 20 to help protect inf ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.